Gene editing for the treatment of primary immunodeficiency disease.
- Author:
Shan LIU
1
;
Shu-Yu FANG
1
;
Yun-Fei AN
1
Author Information
1. Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University/National Clinical Research Center for Child Health and Disorders/Ministry of Education Key Laboratory of Child Development and Disorders/Chongqing Key Laboratory of Child Infection and Immunity, Chongqing 400014, China.
- Publication Type:Review
- MeSH:
Gene Editing;
Humans;
Primary Immunodeficiency Diseases
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(7):743-748
- CountryChina
- Language:Chinese
-
Abstract:
Gene editing is an advanced technique based on artificial nucleases and can precisely modify genome sequences. It has shown great application prospects in the field of medicine and has provided a new precision therapy for diseases. Primary immunodeficiency disease is a group of diseases caused by single gene mutation and characterized by recurrent and refractory infections, with an extremely high mortality rate. The application of gene editing has brought hope for curing these diseases. This article reviews the development of gene editing technology and briefly introduces the research and application of gene editing technology in primary immunodeficiency disease.
